-
Our Story
Recognizing the critical need for timely and precise ..
-
Mission
To empower healthcare providers..
-
Technology
Our technology is built on a cutting-edge..
-
Products
Rapid, Real-Time Sepsis Detection..
About us
Our Story
Petra Biosystems was founded at the IIT Madras Research Park with a vision to tackle some of the most pressing and unresolved challenges in healthcare. Recognizing the critical need for timely and precise patient monitoring in intensive care, our founders set out to create a platform that empowers clinicians with actionable insights in real time. Supported by Petra Group, a company dedicated to solutions for humanity, Petra Biosystems combines scientific rigor with entrepreneurial drive. From the very beginning, our goal has been to translate cutting-edge microfluidic and biomedical technologies into tools that can meaningfully improve patient outcomes, especially in critical care settings where every second counts.
Speed, Accuracy, Adaptability
Why we stand apart
Rapid measurement
Detects physiological changes early, enabling faster and more effective interventions.
Real-time data integration
Provides continuous monitoring and clear trend visualization for informed clinical decisions.
Multiplexing capability
Measures multiple biomarkers simultaneously from a single sample, enhancing efficiency.
ICU compatibility
Compact, automated, and designed to integrate with existing critical care workflows without disruption.
User-friendly interface
Real-time monitoring at a glance — improving diagnosis and supporting immediate patient care.
Product
Key features
Versatile Applications
Useful for broader understanding of gasotransmitters in health.
Life-Saving Speed
Reduces sepsis detection time from days to minutes.
Clinically Relevant
Operates under real-world hospital environments.
Point-of-Care Ready
Portable and designed for bedside or emergency use.
Real-Time Biomarker Measurement
Accurately detects gasotransmitter levels in patient blood
Clinical Focus – Critical Diseases
Petra Biosystems’ microfluidic platform is designed to provide continuous, real-time monitoring of critical biomarkers, enabling clinicians to make faster, more informed decisions. By addressing gaps in current diagnostic methods, our technology supports a wide range of applications in healthcare, from intensive care units to clinical research and future personalized medicine initiatives.
Cytokine Storms
Systemic Inflammatory Response Syndrome (SIRS)
Sepsis
Technology
Whom We Serve
ICU Patient Monitoring
The platform integrates seamlessly into ICU workflows, offering continuous bedside monitoring that reduces the need for repeated blood draws while providing a comprehensive view of patient health.
Emergency & Trauma Care
In high-pressure emergency or trauma settings, rapid decision-making is crucial. Real-time biomarker monitoring supports faster triage and targeted treatment, helping clinicians prioritize critical interventions.
Clinical Trials & Research Labs
Our technology also serves as a powerful research tool for studying disease progression, evaluating new therapies, and validating biomarkers. Multiplexed measurement capabilities allow researchers to collect robust, high-resolution data in real time.
Future Expansion
Looking ahead, our platform has the potential for personalized medicine applications and remote patient monitoring, enabling continuous health assessment outside the hospital and proactive management of high-risk populations.
Target Audience
Research
For improving outcomes and studying disease progress
Clinic
For timely intervention and accurate results
ICU, CCU patients
For rapid diagnosis and prognosis
Mission
25+ Years Of Experience
